News
TXG
20.12
-5.85%
-1.25
A Look At 10x Genomics (TXG) Valuation After The Atera Spatial Biology Platform Launch
Simply Wall St · 16h ago
10x Genomics (TXG) Price Target Increased by 12.41% to 23.75
NASDAQ · 1d ago
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?
NASDAQ · 2d ago
Weekly Report: what happened at TXG last week (0420-0424)?
Weekly Report · 2d ago
Is 10x Genomics (TXG) Price Reflecting Its Mixed Valuation Signals After Strong 1-Year Run
Simply Wall St · 5d ago
Thermo Fisher ranks sixth by Quant as stock falls on Q1 results
Seeking Alpha · 6d ago
Why 10x Genomics (TXG) Shares Are Trading Lower Today
Barchart · 6d ago
Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)?
Simply Wall St · 04/21 17:04
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Brookdale Senior Living (BKD) and 10x Genomics (TXG)
TipRanks · 04/21 09:01
10x Genomics Is Maintained at Buy by Canaccord Genuity
Dow Jones · 04/20 16:27
10x Genomics Price Target Raised to $32.00/Share From $22.00 by Canaccord Genuity
Dow Jones · 04/20 16:27
Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $32
Benzinga · 04/20 16:17
10x Genomics Is Maintained at Neutral by B of A Securities
Dow Jones · 04/20 15:50
10x Genomics Price Target Raised to $30.00/Share From $21.00 by B of A Securities
Dow Jones · 04/20 15:50
B of A Securities Maintains Neutral on 10x Genomics, Raises Price Target to $30
Benzinga · 04/20 15:40
10x Genomics price target raised to $32 from $22 at Canaccord
TipRanks · 04/20 14:03
10x Genomics price target raised to $30 from $21 at BofA
TipRanks · 04/20 13:43
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Fennec Pharmaceuticals (FENC) and Cigna (CI)
TipRanks · 04/20 11:11
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)
TipRanks · 04/20 10:11
Weekly Report: what happened at TXG last week (0413-0417)?
Weekly Report · 04/20 09:19
More
Webull provides a variety of real-time TXG stock news. You can receive the latest news about 10X Genomics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.